Annual EBITDA
-$9.88 M
+$4.73 M+32.38%
December 31, 2023
Summary
- As of February 12, 2025, MNOV annual EBITDA is -$9.88 million, with the most recent change of +$4.73 million (+32.38%) on December 31, 2023.
- During the last 3 years, MNOV annual EBITDA has risen by +$4.28 million (+30.21%).
- MNOV annual EBITDA is now -390.32% below its all-time high of -$2.02 million, reached on December 31, 2001.
Performance
MNOV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.30 M
-$262.80 K-8.64%
September 30, 2024
Summary
- As of February 12, 2025, MNOV quarterly EBITDA is -$3.30 million, with the most recent change of -$262.80 thousand (-8.64%) on September 30, 2024.
- Over the past year, MNOV quarterly EBITDA has dropped by -$173.30 thousand (-5.54%).
- MNOV quarterly EBITDA is now -196.48% below its all-time high of $3.42 million, reached on December 31, 2013.
Performance
MNOV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$11.96 M
-$2.16 M-22.07%
September 30, 2024
Summary
- As of February 12, 2025, MNOV TTM EBITDA is -$11.96 million, with the most recent change of -$2.16 million (-22.07%) on September 30, 2024.
- Over the past year, MNOV TTM EBITDA has dropped by -$1.91 million (-18.99%).
- MNOV TTM EBITDA is now -268.22% below its all-time high of -$3.25 million, reached on June 30, 2014.
Performance
MNOV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MNOV EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +32.4% | -5.5% | -19.0% |
3 y3 years | +30.2% | -0.3% | +10.6% |
5 y5 years | +36.5% | -0.3% | +10.6% |
MNOV EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +32.4% | -189.5% | +19.1% | -22.1% | +18.1% |
5 y | 5-year | at high | +32.4% | -1593.4% | +26.7% | -22.1% | +18.1% |
alltime | all time | -390.3% | +81.3% | -196.5% | +84.2% | -268.2% | +80.8% |
MediciNova EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$3.30 M(+8.6%) | -$11.96 M(+22.1%) |
Jun 2024 | - | -$3.04 M(-2.9%) | -$9.80 M(-2.5%) |
Mar 2024 | - | -$3.13 M(+26.0%) | -$10.05 M(+1.7%) |
Dec 2023 | -$9.88 M(-32.4%) | -$2.48 M(+117.7%) | -$9.88 M(-7.0%) |
Sep 2023 | - | -$1.14 M(-65.4%) | -$10.62 M(-20.6%) |
Jun 2023 | - | -$3.29 M(+11.4%) | -$13.37 M(-5.6%) |
Mar 2023 | - | -$2.96 M(-8.3%) | -$14.16 M(-3.1%) |
Dec 2022 | -$14.61 M(+43.4%) | -$3.23 M(-17.1%) | -$14.61 M(+8.4%) |
Sep 2022 | - | -$3.89 M(-4.7%) | -$13.48 M(+2.3%) |
Jun 2022 | - | -$4.09 M(+20.0%) | -$13.18 M(-1.6%) |
Mar 2022 | - | -$3.41 M(+62.4%) | -$13.40 M(+31.5%) |
Dec 2021 | -$10.19 M(-28.0%) | -$2.10 M(-41.7%) | -$10.19 M(-8.2%) |
Sep 2021 | - | -$3.59 M(-16.5%) | -$11.10 M(-1.2%) |
Jun 2021 | - | -$4.30 M(+2105.7%) | -$11.23 M(-1.8%) |
Mar 2021 | - | -$195.10 K(-93.5%) | -$11.43 M(-19.2%) |
Dec 2020 | -$14.16 M(+1.1%) | -$3.01 M(-19.3%) | -$14.16 M(+5.9%) |
Sep 2020 | - | -$3.72 M(-17.3%) | -$13.37 M(+8.8%) |
Jun 2020 | - | -$4.51 M(+54.3%) | -$12.28 M(+2.8%) |
Mar 2020 | - | -$2.92 M(+31.6%) | -$11.95 M(-14.7%) |
Dec 2019 | -$14.01 M(-10.0%) | -$2.22 M(-16.0%) | -$14.01 M(+14.1%) |
Sep 2019 | - | -$2.64 M(-36.8%) | -$12.27 M(-26.3%) |
Jun 2019 | - | -$4.18 M(-16.0%) | -$16.66 M(+4.9%) |
Mar 2019 | - | -$4.97 M(+923.1%) | -$15.87 M(+2.0%) |
Dec 2018 | -$15.56 M(+19.7%) | -$486.10 K(-93.1%) | -$15.56 M(-15.8%) |
Sep 2018 | - | -$7.02 M(+106.9%) | -$18.48 M(+21.2%) |
Jun 2018 | - | -$3.39 M(-27.2%) | -$15.24 M(+4.1%) |
Mar 2018 | - | -$4.66 M(+37.0%) | -$14.64 M(+12.6%) |
Dec 2017 | -$13.00 M(+19.6%) | -$3.40 M(-10.1%) | -$13.00 M(+17.8%) |
Sep 2017 | - | -$3.78 M(+35.3%) | -$11.04 M(+9.3%) |
Jun 2017 | - | -$2.80 M(-7.2%) | -$10.09 M(-3.8%) |
Mar 2017 | - | -$3.02 M(+109.8%) | -$10.50 M(-3.4%) |
Dec 2016 | -$10.87 M(+23.3%) | -$1.44 M(-49.4%) | -$10.87 M(-10.8%) |
Sep 2016 | - | -$2.84 M(-11.2%) | -$12.18 M(+11.5%) |
Jun 2016 | - | -$3.20 M(-5.5%) | -$10.92 M(+9.3%) |
Mar 2016 | - | -$3.39 M(+23.3%) | -$9.99 M(+13.4%) |
Dec 2015 | -$8.81 M(-3.8%) | -$2.75 M(+72.9%) | -$8.81 M(+4.7%) |
Sep 2015 | - | -$1.59 M(-30.0%) | -$8.41 M(-8.1%) |
Jun 2015 | - | -$2.27 M(+2.8%) | -$9.16 M(+1.6%) |
Mar 2015 | - | -$2.21 M(-6.1%) | -$9.01 M(-1.5%) |
Dec 2014 | -$9.16 M(+133.4%) | -$2.35 M(+0.6%) | -$9.15 M(+171.2%) |
Sep 2014 | - | -$2.34 M(+10.1%) | -$3.37 M(+3.8%) |
Jun 2014 | - | -$2.12 M(-9.4%) | -$3.25 M(-16.2%) |
Mar 2014 | - | -$2.34 M(-168.3%) | -$3.88 M(-1.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2013 | -$3.92 M(-63.9%) | $3.42 M(-254.9%) | -$3.92 M(-59.7%) |
Sep 2013 | - | -$2.21 M(-19.6%) | -$9.74 M(-1.4%) |
Jun 2013 | - | -$2.75 M(+15.2%) | -$9.88 M(+5.1%) |
Mar 2013 | - | -$2.39 M(-0.1%) | -$9.40 M(-13.5%) |
Dec 2012 | -$10.88 M(-32.4%) | -$2.39 M(+1.5%) | -$10.88 M(-9.1%) |
Sep 2012 | - | -$2.35 M(+3.5%) | -$11.97 M(-11.4%) |
Jun 2012 | - | -$2.27 M(-41.1%) | -$13.51 M(-9.7%) |
Mar 2012 | - | -$3.86 M(+10.8%) | -$14.97 M(-7.0%) |
Dec 2011 | -$16.09 M(-12.1%) | -$3.48 M(-10.6%) | -$16.10 M(-4.9%) |
Sep 2011 | - | -$3.90 M(+4.6%) | -$16.92 M(-6.2%) |
Jun 2011 | - | -$3.73 M(-25.3%) | -$18.04 M(-1.0%) |
Mar 2011 | - | -$4.99 M(+15.9%) | -$18.21 M(-0.5%) |
Dec 2010 | -$18.30 M(-8.1%) | -$4.31 M(-14.1%) | -$18.30 M(-7.5%) |
Sep 2010 | - | -$5.01 M(+28.5%) | -$19.78 M(+1.7%) |
Jun 2010 | - | -$3.90 M(-23.2%) | -$19.46 M(-3.1%) |
Mar 2010 | - | -$5.08 M(-12.3%) | -$20.09 M(-0.6%) |
Dec 2009 | -$19.90 M(-10.7%) | -$5.79 M(+23.4%) | -$20.21 M(+15.9%) |
Sep 2009 | - | -$4.69 M(+3.5%) | -$17.44 M(-5.1%) |
Jun 2009 | - | -$4.53 M(-12.9%) | -$18.38 M(+0.7%) |
Mar 2009 | - | -$5.20 M(+72.4%) | -$18.25 M(-15.9%) |
Dec 2008 | -$22.30 M(-57.9%) | -$3.02 M(-46.4%) | -$21.71 M(-3.3%) |
Sep 2008 | - | -$5.63 M(+28.0%) | -$22.45 M(-19.9%) |
Jun 2008 | - | -$4.40 M(-49.2%) | -$28.02 M(-37.0%) |
Mar 2008 | - | -$8.66 M(+130.7%) | -$44.51 M(-16.4%) |
Dec 2007 | -$52.98 M(+27.1%) | -$3.75 M(-66.5%) | -$53.26 M(-14.7%) |
Sep 2007 | - | -$11.21 M(-46.3%) | -$62.45 M(+1.9%) |
Jun 2007 | - | -$20.89 M(+19.9%) | -$61.31 M(+24.8%) |
Mar 2007 | - | -$17.41 M(+34.5%) | -$49.11 M(+18.2%) |
Dec 2006 | -$41.68 M(+38.5%) | -$12.95 M(+28.7%) | -$41.56 M(+11.8%) |
Sep 2006 | - | -$10.06 M(+15.8%) | -$37.15 M(+6.8%) |
Jun 2006 | - | -$8.69 M(-11.8%) | -$34.80 M(+1.0%) |
Mar 2006 | - | -$9.86 M(+15.3%) | -$34.45 M(+14.6%) |
Dec 2005 | -$30.09 M(-38.0%) | -$8.54 M(+10.9%) | -$30.06 M(+17.2%) |
Sep 2005 | - | -$7.71 M(-7.6%) | -$25.64 M(-28.1%) |
Jun 2005 | - | -$8.34 M(+52.3%) | -$35.66 M(-24.7%) |
Mar 2005 | - | -$5.48 M(+32.8%) | -$47.36 M(-2.5%) |
Dec 2004 | -$48.57 M(+679.4%) | -$4.12 M(-76.7%) | -$48.57 M(+9.3%) |
Sep 2004 | - | -$17.72 M(-11.6%) | -$44.44 M(+66.3%) |
Jun 2004 | - | -$20.04 M(+199.8%) | -$26.73 M(+299.8%) |
Mar 2004 | - | -$6.68 M | -$6.68 M |
Dec 2003 | -$6.23 M(-11.1%) | - | - |
Dec 2002 | -$7.01 M(+248.0%) | - | - |
Dec 2001 | -$2.02 M | - | - |
FAQ
- What is MediciNova annual EBITDA?
- What is the all time high annual EBITDA for MediciNova?
- What is MediciNova annual EBITDA year-on-year change?
- What is MediciNova quarterly EBITDA?
- What is the all time high quarterly EBITDA for MediciNova?
- What is MediciNova quarterly EBITDA year-on-year change?
- What is MediciNova TTM EBITDA?
- What is the all time high TTM EBITDA for MediciNova?
- What is MediciNova TTM EBITDA year-on-year change?
What is MediciNova annual EBITDA?
The current annual EBITDA of MNOV is -$9.88 M
What is the all time high annual EBITDA for MediciNova?
MediciNova all-time high annual EBITDA is -$2.02 M
What is MediciNova annual EBITDA year-on-year change?
Over the past year, MNOV annual EBITDA has changed by +$4.73 M (+32.38%)
What is MediciNova quarterly EBITDA?
The current quarterly EBITDA of MNOV is -$3.30 M
What is the all time high quarterly EBITDA for MediciNova?
MediciNova all-time high quarterly EBITDA is $3.42 M
What is MediciNova quarterly EBITDA year-on-year change?
Over the past year, MNOV quarterly EBITDA has changed by -$173.30 K (-5.54%)
What is MediciNova TTM EBITDA?
The current TTM EBITDA of MNOV is -$11.96 M
What is the all time high TTM EBITDA for MediciNova?
MediciNova all-time high TTM EBITDA is -$3.25 M
What is MediciNova TTM EBITDA year-on-year change?
Over the past year, MNOV TTM EBITDA has changed by -$1.91 M (-18.99%)